Statistics for Voyager Therapeutics (id:8104 VYGR)

Valuation metrics

Market cap

308.91M

Enterprise value

-3,396,068.00

Trailing P/E (ttm)

8.57

Forward P/E

-3.37

PEG ratio

-3.37

Price/Sales (ttm)

1.89

Price/Book (mrq)

0.93

Enterprise Value/Revenue

-0.02

Enterprise Value/EBITDA

-0.24

Overview

Shares outstanding

54.63M

Float

36.30M

Shares short

2.95M

% Held by insiders

0.17%

% Held by institutions

0.65%

Average volume (10 days)

582.34K

Average volume (90 days)

Price summary

52-Week low

5.19

52-Week high

11.72

52-Week change

-22.26%

Beta

0.89

50-Day moving average

6.55

200-Day moving average

7.77

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

15.80%

Operating margin

-55.95%

Operational effectiveness

Return on assets

1.57%

Return on equity

10.22%

Income statement

Revenue (ttm)

2.95

Revenue per share (ttm)

2.95

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

126.46M

Net income to common (ttm)

25.88M

Diluted EPS (ttm)

0.66

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

345.36M

Total cash per share (mrq)

6.32

Total debt (mrq)

45.35M

Total Debt/Equity (mrq)

13.73

Current ratio (mrq)

844.70%

Book value per share (mrq)

6.06

Cash flow

Cash flow statement

-24,541,000.00

Levered free cash flow (LFCF)

-19,746,124.00